Post Featured Image

Neuspera™ Raises $8M to Back Tiny, Injectable Neuromodulation Technology

NeuSpera™ Medical had been working under the radar for some time on about $1 million in angel financing. Now, it's raised an $8 million Series A financing after bringing in a high-profile exec to lead its effort. The Santa Clara, CA-based startup is aiming for a futuristic field that already has substantial strategic interest: electroceuticals.

GlaxoSmithKline ($GSK) declared its interest in electroceuticals, also known as bioelectronics, a few years ago. The idea is that miniature devices can be used to modulate the electrical impulses in the body, thereby triggering biochemical processes that are more typically manipulated via biopharmaceuticals. The end game is to replace drug therapies by inducing the body to heal itself in major illnesses that could include diabetes, asthma, hypertension, arthritis, pain and even cancer.

The biopharma has put its money where its mouth is with a couple of financing initiatives including a $50 million venture fund. GSK has funded at least 33 electroceuticals, mostly in very early research stages.

NeuSpera™ claims that its implant is more than 100 times smaller than other neuromodulation devices. It expects its miniaturized injectable neuromodulation technology could treat patients with chronic illnesses. Its small form factor is expected to reduce procedure complexity and time as well as patient complications and post-surgical pain. The tech is powered by the company's MidField technology.

It's not quite clear yet if NeuSpera™ is aiming for the more traditional function of neuromodulation, pain management, with a smaller form factor--or if it's actually seeking to address tackle underlying disease processes. Either way, it's staked itself out as an electroceuticals company.

The company was founded in 2014 as Vivonda Medical. Last August, it brought in former Cyberonics SVP of R&D Milton Morris. He was first tasked with a Series A fundraising. Morris left Cyberonics in the shake-up after the $3 billion merger with Sorin to create LivaNova ($LIVN).

"It is a privilege to be in a position to positively impact human lives through medical technology--a privilege that I take seriously," said Morris in a statement when he was appointed as the startup's CEO. "NeuSpera™ has the opportunity to fundamentally change the way neuromodulation therapy is delivered. I look forward to realizing its great potential."

The SEC filing can be found by clicking here.

12 comments (Add your own)

1. wrote:
I'm really inspired along with your writing talents as smartly as with the structure on your blog.
Is that this a paid topic or did you modify it yourself?

Either way keep up the nice high quality writing, it's uncommon to peer a great weblog like this one these days.

Sat, August 18, 2018 @ 3:41 PM

2. wrote:
As I website possessor I believe the content material here
is rattling fantastic , appreciate it for your efforts. You should keep it up forever!
Good Luck.

Sat, August 18, 2018 @ 3:48 PM

3. wrote:
Howdy! I could have sworn I've visited this website before but
after looking at many of the posts I realized it's new to me.
Anyways, I'm certainly pleased I came across it and I'll be book-marking it and checking back frequently!

Fri, August 31, 2018 @ 1:02 PM

4. wrote:
Hmm it looks like your blog ate my first comment (it wass extremely long) soo I guess I'll just sum
it up what I submitted and say, I'm thoroughly enjoying
your blog. I too am an aspiring blog writer but I'm still new
to everything. Do you have any tips for beginnr blog writers?
I'd definitely appreciate it.

Tue, September 4, 2018 @ 7:38 PM

5. wrote:
This information is invaluable. Where can I find
out more?

Fri, September 7, 2018 @ 6:05 AM

6. wrote:
What i don't realize is in reality how you're now not actually much more smartly-appreciated than you might be right now.
You're very intelligent. You know therefore significantly with regards to this subject, made me personally believe it from numerous various angles.

Its like women and men are not fascinated unless it is something to accomplish with
Girl gaga! Your personal stuffs outstanding. Always deal with it up!

Fri, September 7, 2018 @ 12:08 PM

7. wrote:
Does your site have a contact page? I'm having trouble locating it but, I'd like to shoot you an e-mail.
I've got some creative ideas for your blog you might be interested in hearing.
Either way, great blog and I look forward to seeing it expand over time.

Fri, September 7, 2018 @ 9:14 PM

8. wrote:
Amazing blog! Is your theme custom made or did you download it from somewhere?
A design like yours with a few simple tweeks would really make my blog jump out.
Please let me know where you got your theme.
Thanks a lot

Sat, September 8, 2018 @ 4:29 AM

9. wrote:
After looking into a number of the blog posts on your web site, I seriously like your way
of blogging. I saved as a favorite it to my bookmark webpage list and will be checking back in the near future.
Take a look at my website too and let me know your opinion.

Wed, September 12, 2018 @ 4:17 AM

10. wrote:
This excellent website really has all the information and facts I needed about this subject and didn't know who
to ask.

Sun, September 16, 2018 @ 7:23 AM

11. wrote:
Hey there, You have done an excellent job.

I'll certainly digg it and personally suggest to my friends.
I am sure they will be benefited from this site.

Thu, September 20, 2018 @ 2:56 PM

12. wrote:
Terrific article! This is the type of info that are
meant to be shared across the net. Disgrace on Google
for no longer positioning this post higher! Come on over and talk over with
my site . Thanks =)

Sun, September 23, 2018 @ 10:37 PM

Add a New Comment


Comment Guidelines: No HTML is allowed. Off-topic or inappropriate comments will be edited or deleted. Thanks.